Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EQ Equillium Inc.

交易中 07-21 13:24:17 EDT

2.59

+0.12

+4.86%

最高2.64	最低2.47	成交量27.97万
今开2.50	昨收2.47	日振幅6.88%
总市值1.64亿	流通市值9,178万	总股本6,323万
成交额71.90万	换手率0.79%	流通股本3,544万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EQ","market":"US","secType":"STK","nameCN":"Equillium Inc.","latestPrice":2.59,"timestamp":1784654650331,"preClose":2.47,"halted":0,"volume":279718,"delay":0,"changeRate":0.048582995951416866,"floatShares":35435700,"shares":63226556,"eps":-0.30137652,"marketStatus":"交易中","change":0.12,"latestTime":"07-21 13:24:17 EDT","open":2.5,"high":2.64,"low":2.47,"amount":719013.2169176,"amplitude":0.068826,"askPrice":2.59,"askSize":21,"bidPrice":2.58,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.30137652,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784664000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1539316800000,"exchange":"NASDAQ","adjPreClose":2.47,"preHourTrading":{"tag":"盘前","latestPrice":2.47,"preClose":2.47,"latestTime":"04:00 EDT","volume":50,"amount":123.50000000000001,"timestamp":1784620812586,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.47,"latestTime":"19:53 EDT","volume":664,"amount":1641.968,"timestamp":1784591602269,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.22927,"impliedVol":1.7695,"impliedVolPercentile":0.7888},"requestUrl":"/m/hq/s/EQ","defaultTab":"news","newsList":[{"id":"2652693232","title":"1.9亿澳元豪赌战略金属！矿业大鳄接盘EQ Resources，引爆股价狂飙32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652693232","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652693232?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:35","pubTimestamp":1784514941,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","REMX","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641310144","title":"IQ-EQ任命亚太区资产所有者主管 反映区域服务业务的拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2641310144","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641310144?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:20","pubTimestamp":1780903230,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，全球投资者服务集团IQ-EQ任命Wyn James为亚太区资产所有者新任主管。他常驻新加坡，将领导并推动IQ-EQ在亚太地区的资产所有者业务板块发展。根据公司声明，其新设立的职位反映了IQ-EQ在亚太地区对机构资产所有者的日益重视，包括主权财富基金、养老基金、保险公司和家族办公室。声明称，Wyn James的任命标志着公司加强专门针对机构资产所有者特定需求的亚太市场服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","BK4139","BK4552","BK4526","IQ","EQ","BK4108","BK4505","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629584893","title":"东风汽车全新一代概念车EQ-REBORN亮相，致敬1975年军车","url":"https://stock-news.laohu8.com/highlight/detail?id=2629584893","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629584893?lang=zh_cn&edition=full","pubTime":"2026-04-24 09:37","pubTimestamp":1776994638,"startTime":"0","endTime":"0","summary":"IT之家 4 月 24 日消息，在今日的 2026 东风汽车北京国际车展发布会上，东风汽车全新一代概念车正式亮相。这款概念车灵感来自东风 1975 年的 EQ240 军车，定名 EQ-REBORN。该车的造型方正，车头处配有点阵屏可显示信息，车顶配有多个无人机，定位智能轻越野车型。IT之家注意到，发布会现场只展示了该车的外观和部分内饰画面，配置信息暂未公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8sZyfreKSxc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["00489","EQ","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK4139","BK1523","BK1539","BK4568","BK1119"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183859739","title":"Equillium Inc. 股东售股计划：包含可行使预融资权证发行的1770万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1183859739","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183859739?lang=zh_cn&edition=full","pubTime":"2026-04-08 05:17","pubTimestamp":1775596630,"startTime":"0","endTime":"0","summary":"Equillium Inc. 宣布其股东售股计划中，包含一项重要条款：通过行使预融资权证，可发行高达1770万股的公司普通股。这一安排为股票的潜在增发提供了明确路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186611042","title":"Equillium获RA资本管理3500万美元融资 加速EQ504临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1186611042","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186611042?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:05","pubTimestamp":1773403550,"startTime":"0","endTime":"0","summary":"此次融资将强化公司资产负债表，推动关键候选药物EQ504跨越临床里程碑。预计净收益与现有现金储备将支撑公司运营至2029年。2026年3月13日，专注于治疗严重自身免疫及炎症疾病的生物技术公司Equillium Inc.宣布与RA资本管理达成最终证券购买协议，后者将提供约3500万美元的总融资。在扣除相关费用前，本次融资总额预计达3500万美元。Equillium认为EQ504单药或联合疗法在溃疡性结肠炎领域具有广阔治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617570598","title":"“新物种”Robot Phone能给手机硬件创新带来什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2617570598","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617570598?lang=zh_cn&edition=full","pubTime":"2026-03-05 08:07","pubTimestamp":1772669232,"startTime":"0","endTime":"0","summary":"【“新物种”Robot Phone能给手机硬件创新带来什么？】新物种“RobotPhone”在2026年世界移动通信大会（MWC26）上引起了不小的关注度。3月3日，MWC第二天，荣耀的MWC展台依然挤满了观众，人们在围观新物种“Robot Phone”。舞台上有舞者在跳舞，Robot Phone通过延伸出的镜头来追踪舞者的动作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603053662396561.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603053662396561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2247934214.USD","BK4587","BK4588","LU0081259029.USD","LU0061475181.USD","LU1035775433.USD","SG9999001424.SGD","LU1084165304.USD","BK4543","BK4598","IE00BVYPNQ40.USD","QCOM","BK4505","BK4575","LU1917777945.USD","QCMU","SG9999015978.USD","LU1823568750.SGD","SG9999015952.SGD","LU2023250504.SGD","GB00BDT5M118.USD","BK4573","BK4579","EQ","LU1069344957.HKD","BK4561","LU2106854487.HKD","BK4512","BK4528","BK4554","QCML","BK4534","LU1244550494.USD","AIYY","LU1974910355.USD","QCMD","SG9999002232.USD","BK4551","BK4526","LU1046421795.USD","BK4552","IE00BGHQDM52.EUR","IQ","BK4515","BK4023","BK4612","LU0868494617.USD","SG9999002224.SGD","BK4605"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616144822","title":"荣耀CEO李健提出AHI理念：让AI既有IQ又有EQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2616144822","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616144822?lang=zh_cn&edition=full","pubTime":"2026-03-01 20:33","pubTimestamp":1772368380,"startTime":"0","endTime":"0","summary":"新浪科技讯 北京时间3月1日晚间消息，在今日的荣耀MWC 2026全球发布会上，荣耀CEO李健发表演讲。\n　　他提出Augmented Human Intelligence（简称AHI）理念，以实现AI从智能度到生命感的双重跃升，让AI既有IQ，又有EQ，并创造性地将AHI理念融入其阿尔法战略落地进程中。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：何俊熹","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2026-03-01/doc-inhpnwmn6008247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4568","EQ","AHI","BK4108","BK4167","BK4552","IQ","BK4139","BK4505","BK4097","BK4526","BK4531"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614127001","title":"Equillium, Inc.盘中异动 早盘急速下挫6.01%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614127001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614127001?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:02","pubTimestamp":1772118120,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日23时02分，Equillium, Inc.股票出现异动，股价急速跳水6.01%。截至发稿，该股报1.72美元/股，成交量5.1943万股，换手率0.09%，振幅8.16%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226230200a4cc0a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226230200a4cc0a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613217980","title":"Equillium, Inc.盘中异动 早盘快速跳水5.49%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613217980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613217980?lang=zh_cn&edition=full","pubTime":"2026-02-20 22:47","pubTimestamp":1771598838,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日22时47分，Equillium, Inc.股票出现异动，股价大幅下挫5.49%。截至发稿，该股报1.72美元/股，成交量1.644万股，换手率0.03%，振幅4.40%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220224718954187c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220224718954187c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518372274","title":"Equillium, Inc.盘中异动 早盘大幅下挫8.13%报0.731美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518372274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518372274?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:56","pubTimestamp":1741614969,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时56分，Equillium, Inc.股票出现异动，股价大幅下跌8.13%。截至发稿，该股报0.731美元/股，成交量4859股，换手率0.01%，振幅3.64%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2936.57%、644.95%、177.16%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Impact Biomedical, Inc.，振幅分别为40.24%、30.52%、28.59%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215610abf305cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215610abf305cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517193777","title":"Equillium, Inc.盘中异动 快速拉升5.57%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193777?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:26","pubTimestamp":1741282006,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时26分，Equillium, Inc.股票出现波动，股价快速上涨5.57%。截至发稿，该股报0.760美元/股，成交量2.5922万股，换手率0.07%，振幅7.92%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012646963c6cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012646963c6cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663928","title":"Equillium, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663928?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:37","pubTimestamp":1741034264,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时37分，Equillium, Inc.股票出现波动，股价大幅下挫5.73%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.52%、187.68%、163.60%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514680753","title":"OpenAI发布GPT-4.5！史上最贵AI模型，情商逆天引热议，AI巨头混战即将打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680753","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514680753?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:49","pubTimestamp":1740703799,"startTime":"0","endTime":"0","summary":"2月28日凌晨，OpenAI正式发布了其最新一代基础模型GPT-4.5，这一发布迅速在科技界引起了轩然大波。这款被OpenAI内部代号为“Orion”的模型，不仅被誉为迄今为止规模最大、知识最丰富的聊天模型，更因其高情商和人性化表现而备受瞩目。价格昂贵，引发争议然而，GPT-4.5的高昂价格也成为了人们热议的话题。值得一提的是，OpenAI还计划在未来向免费用户开放GPT-5的使用权限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28084948444186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514354332","title":"实测GPT4.5：更像人了，有惊喜但提升微妙","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354332","media":"AI寒武纪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354332?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:11","pubTimestamp":1740697866,"startTime":"0","endTime":"0","summary":"北京时间凌晨4点钟OpenAI举行一个14分钟左右的直播发布，GPT4.5 终于发布了！知识更渊博，能力更全面除了情商升级， GPT-4.5 的知识储备和能力也得到了显著提升。这次的 GPT-4.5 更是吊足了大家的胃口，毕竟距离 GPT-4 发布已经过去大约两年了！GPT-4: 感觉确实更好，但 Karpathy 也坦言，提升是 微妙的 。GPT-4.5：微妙的提升，依旧令人兴奋带着对 GPT-4 这种“微妙提升”的预期，Karpathy 对 GPT-4.5 进行了测试。这次 GPT-4.5 的预训练算力比 GPT-4 又提升了 10 倍！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdqM","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4526","BK4552","BK4139","BK4505","BK4568","EQ","BK4531","BK4108"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514531453","title":"ChatGPT4.5凌晨发布：不是推理模型，胜似推理模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2514531453","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514531453?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:31","pubTimestamp":1740691902,"startTime":"0","endTime":"0","summary":"凤凰网科技讯 2月28日，OpenAI发布了旗下最新一代大语言模型GhatGPT4.5。相较于GPT-4，GPT-4.5在多个方面进行了优化。GPT-4.5在用户交互中的表现更加自然，知识覆盖面更广，能更好地理解并响应用户的意图。回答问题更加严谨GPT-4.5的核心进展在于其无监督学习的提升。通过增加计算能力和数据规模，GPT-4.5在处理复杂任务时显示出更高的准确性，尤其是在减少“幻觉”现象方面表现突出。OpenAI表示，GPT-4.5仍处于研究预览阶段，未来将继续优化，以便更好地服务于各行各业的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdbw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514132339","title":"Equillium, Inc.盘中异动 股价大涨5.87%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514132339?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:59","pubTimestamp":1740682746,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时59分，Equillium, Inc.股票出现波动，股价大幅上涨5.87%。截至发稿，该股报0.810美元/股，成交量2.9874万股，换手率0.08%，振幅6.54%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1880.38%、320.93%、136.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514866643","title":"Equillium, Inc.盘中异动 快速跳水5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866643?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:07","pubTimestamp":1740593254,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时07分，Equillium, Inc.股票出现异动，股价急速下跌5.78%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6400.71%、261.96%、239.71%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation，振幅分别为194.07%、49.18%、44.44%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020734a255286e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020734a255286e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514539578","title":"梅赛德斯-奔驰将逐步淘汰电动汽车“EQ+X”命名，以“配备 EQ 技术”取代","url":"https://stock-news.laohu8.com/highlight/detail?id=2514539578","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514539578?lang=zh_cn&edition=full","pubTime":"2025-02-26 10:26","pubTimestamp":1740536777,"startTime":"0","endTime":"0","summary":"根据外媒 Automotive News Europe 报道，梅赛德斯-奔驰正逐步淘汰电动汽车上的 EQ 前缀，未来将改用“配备 EQ 技术”后缀 ，而插电式混合动力车型则会添加“配备 EQ 混合动力技术”标签。梅赛德斯-奔驰的一位发言人表示，“我们正在强化传统的命名逻辑，未来新车型将不再使用‘EQ’。”梅赛德斯-奔驰并非唯一调整命名的欧洲豪华品牌。","market":"us","thumbnail":"https://k.sinaimg.cn/n/spider20250226/697/w959h538/20250226/cec8-2c1c922f81bf06deb8a90e9f413caf31.jpg/w120h90l50t15f2.jpg","type":0,"news_type":0,"thumbnails":["https://k.sinaimg.cn/n/spider20250226/697/w959h538/20250226/cec8-2c1c922f81bf06deb8a90e9f413caf31.jpg/w120h90l50t15f2.jpg"],"rights":{"source":"sina_tech","url":"https://tech.sina.cn/mobile/xp/2025-02-26/detail-inemukxn8238835.d.html?vt=4","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}.weibo_user{#sourceStyle#; margin-bottom: 0; display: inline-block;}.weibo_time{#sourceStyle#};","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .j_float_wbro, .j_article_wbreco","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.sina.cn/mobile/xp/2025-02-26/detail-inemukxn8238835.d.html?vt=4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_tech","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514001149","title":"Equillium, Inc.盘中异动 快速跳水6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514001149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514001149?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:21","pubTimestamp":1740500464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时21分，Equillium, Inc.股票出现波动，股价快速下跌6.19%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1323.39%、1114.16%、898.01%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002105a2539ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002105a2539ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720385","title":"Equillium, Inc.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720385?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:59","pubTimestamp":1740409191,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时59分，Equillium, Inc.股票出现波动，股价快速下挫5.44%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为150.95%、65.71%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225951a2521b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225951a2521b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.equilliumbio.com","stockEarnings":[{"period":"1week","weight":-0.1424},{"period":"1month","weight":-0.1902},{"period":"3month","weight":0.1488},{"period":"6month","weight":1.2252},{"period":"1year","weight":4.9504},{"period":"ytd","weight":0.5935}],"compareEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.054},{"period":"6month","weight":0.0827},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Equillium, Inc.于2017年3月16日在特拉华州注册成立，该公司前身为Attenuate Biopharmaceuticals，Inc.。该公司是一家生物技术创新企业，致力于开发治疗严重自身免疫和炎症性疾病的新型疗法。其主要候选药物EQ504是一种处于临床前阶段的AhR调节剂，最初靶向溃疡性结肠炎，此外还包括一个处于临床前阶段、用于胃肠道适应症的口服双特异性抑制剂项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.054449},{"month":2,"riseRate":0.625,"avgChangeRate":0.322617},{"month":3,"riseRate":0.375,"avgChangeRate":-0.15431},{"month":4,"riseRate":0.375,"avgChangeRate":-0.117774},{"month":5,"riseRate":0.75,"avgChangeRate":0.084701},{"month":6,"riseRate":0.25,"avgChangeRate":-0.120031},{"month":7,"riseRate":0.5,"avgChangeRate":0.259504},{"month":8,"riseRate":0.714286,"avgChangeRate":0.556288},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085401},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.070521},{"month":11,"riseRate":0.25,"avgChangeRate":-0.089283},{"month":12,"riseRate":0.5,"avgChangeRate":-0.014533}],"exchange":"NASDAQ","name":"Equillium Inc.","nameEN":"Equillium Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Equillium Inc.,EQ,Equillium Inc.股票,Equillium Inc.股票老虎,Equillium Inc.股票老虎国际,Equillium Inc.行情,Equillium Inc.股票行情,Equillium Inc.股价,Equillium Inc.股市,Equillium Inc.股票价格,Equillium Inc.股票交易,Equillium Inc.股票购买,Equillium Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}